Japan Herald
JapanHerald.com Wednesday 8th February 2012 Issue 2012/0208
Follow us on Follow us on TwitterFollow us on facebook
  		• More Breaking Health News

  		• Nazi medical tools to be auctioned
  		• Choose Hamas or peace with Israel, Netanyahu tells Abbas
  		• President of Maldives quits after weeks of protests
  		• Myanmar reforms leads to US partially lifting embargo
  		• Philippines earthquake toll 48, scores missing
  		• Russian foreign minister in Syria, violence escalates
  		• JAL says first Dreamliner delivery will be delayed
  		• As Greece mulls a proposed crunch, unions strike in protest
  		• Glencore, Xstrata sign giant $90 bn merger
    Get Breaking Health News headlines emailed to you daily.

    Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
    Source: Medical News Today
    Friday 3rd September, 2010  

    Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two ... ...

    Read the full story at Medical News Today


      Email this story to a friend

    Have your say on this story

    Your nickname (required)
    Message